Japan Reaffirms Plan to Deploy Missiles Near Taiwan | The China Show 11/24/2025

UBS notes that Hong Kong IPO momentum remains robust, indicating continued investor appetite for listings in the region. Lenovo’s CFO discussed second-quarter results and the company-level impact of the AI boom, while China tech stocks sold off on AI-related angst, highlighting near-term sector volatility. A former U.S. commerce secretary flagged tariff uncertainty, adding policy risk for China-exposed investors.

Analysis

Market structure: Robust HK IPO momentum disproportionately benefits HKEX (388.HK), global bookrunners (e.g., UBS), and brokerage/prime services who capture front-loaded fee pools; however, rising supply risks compressing deal pricing and first-day pops if monthly IPO proceeds exceed ~$3bn for two consecutive months. Competitive dynamics favor firms controlling distribution to China onshore institutions and retail placements; issuers without strong onshore demand will face higher discounting. Cross-asset: China equity weakness pushes RMB/FX pressure vs USD, raises CDS spreads and short-term HKD funding volatility, and can steepen U.S.–China risk premia impacting sovereign and corporate bond spreads.

Risk assessment: Near-term tail risk centers on abrupt policy moves — e.g., new U.S. export controls or tariffs >10% that hit supply chains — which would force re-rating within days and could trigger 15–30% downside in levered Chinese tech names. Over weeks–months, an overhang of new listings could flip demand into supply-driven drawdowns; over quarters, AI capex supports semiconductor and data-center equipment demand, partially offsetting platform weakness. Hidden dependencies include HKD peg resilience, onshore allocation quotas, and liquidity from Mainland brokers; catalysts: US tariff announcements, large IPO pricing misses, or HKEX rule changes.

Trade implications: Favor fee-capture longs and volatility hedges: go long HKEX (388.HK) and selected global banks (UBS) for 3–6 months to harvest advisory revenue, size 1–3% each; hedge China-tech beta with 3-month 25-delta puts on KWEB sized to 1% portfolio to limit downside over the next 60–90 days. Consider a 3-month pair: long Lenovo (0992.HK) 1–2% vs short BABA 1% to express hardware/AI capex outperformance vs platform/regulatory exposure.

Contrarian angles: The market may be underestimating differentiated onshore revenue resilience — domestically oriented SaaS and enterprise infra names could outperform despite headline AI angst; conversely, IPO froth could be overdone and create buying opportunities in 6–12 months as weaker entrants reprice. Watch for sustained >$3bn/month IPO proceeds, or a >10% tariff/change in export policy as triggers to materially change positioning.

Key Decisions for Investors

• Establish a 2–3% long position in HKEX (388.HK) within 2–4 weeks to capture continued IPO fee tailwinds; set a take-profit at +15% or trim if monthly HK IPO proceeds fall below $2bn for two consecutive months.
• Allocate 1–2% long to UBS (UBS) as a play on global bookrunning and advisory fees over a 3–6 month horizon; use a hard stop-loss of 8% and take profits if position appreciates by 15% or if IB revenue misses consensus.
• Reduce US-listed China internet exposure by 25% over the next 30 days and buy 3-month 25-delta puts on KWEB sized to 1% of portfolio value (protects against a 15–30% downside move over 60–90 days).
• Implement a 3-month pair trade: long Lenovo (0992.HK) 1–2% vs short Alibaba (BABA) 1% to capture AI-capex upside in hardware vs regulatory/tariff vulnerability in platforms; exit if spread narrows >10% or after 90 days.
• If monthly HK IPO proceeds exceed $3bn for two consecutive months, rotate 1–2% from general China tech longs into semiconductor/equipment names (data-center suppliers) over the following 30 days to play secular AI capex.